WithMe Health

The firm primarily serves self-insured employers and health plans, aiming to reduce their pharmacy costs while improving member outcomes. WithMe Health's business model is centered on a transparent, pass-through structure, charging a per-member-per-month (PMPM) administrative fee rather than relying on traditional PBM revenue streams like rebates. This approach has reportedly resulted in significant savings for clients, with one analysis confirming an average 29% reduction in PMPM pharmacy costs. The company's platform utilizes technology and data analytics, including AI, to assimilate pharmacy, medical, and lab data, creating a comprehensive clinical view for each member. This technological foundation supports its primary service: Personalized Medication Guidance.

The service connects members with a team of clinical pharmacists, known as Medication Guides, who provide support and guidance. These guides engage proactively with members through an app to assist with utilization management, address side effects, and ensure the prescribed medications are effective. This human-led, tech-enabled approach has been a key differentiator, contributing to a high member Net Promoter Score of 85. Over its active years, WithMe Health raised over $40 million in funding from investors such as Oak HC/FT, OMERS Ventures, and Cox Enterprises. In late 2023, the company began an orderly wind-down process and was subsequently acquired by SmithRx in January 2024.